In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

along with its partner Moffitt Cancer Center ("Moffitt"), has received approval for an amendment to the protocol governing its ongoing clinical trial using CAR-T therapy for the treatment of ...

Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio, Senior Trial Design Lead, ...

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you’ve got to do all your CRF designs; keep up with protocol changes; add the ...

PRM is the first stage in the clinical trial planning process. It’s a conceptual model that identifies items in the protocol and organizes them into a machine-readable structure. According to ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast cancer, an essential requirement for filing an Investigational New Drug ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...